Conformis Overview
Compare Conformis's DCF valuation ($2.9) to today's market price.
Get informed when a big investor buys or sells
+ Follow$2.87
Undervalued by 26.6% based on the discounted cash flow analysis.
Conformis (CFMS) currently reports a DCF fair value of $2.9. Use the charts on this page to explore Conformis's DCF fair value history and peer comparisons.
Conformis's discounted cash flow (DCF) fair value estimate is $2.9, about 26.6% undervalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $2.9, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Conformis, and consider following CFMS for alerts when major investors trade the stock.
Conformis is classified in the Healthcare sector. On DCF fair value, it currently shows $2.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CFMS with unrelated industries.
